v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows from Operating Activities:    
Net income (loss) $ (47,766) $ 2,583
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation expense 320 487
Impairment of fixed assets   82
Loss on the disposal of fixed assets   11
Non-cash stock compensation expense 4,310 1,364
Non-cash lease expense 186 151
Non-cash interest expense 79 69
Change in fair value of warrant liabilities 4,635 (20,572)
Accretion of debt discount 622 76
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (1,068) (1,771)
Other assets (11) 18
Accounts payable 4,082 1,513
Accrued expenses (346) (1,243)
Deferred income (44)  
Lease liability (218) (275)
Net cash used in operating activities (35,219) (17,507)
Cash Flows from Investing Activities:    
Purchase of fixed assets (744) (34)
Net cash used in investing activities (744) (34)
Cash Flows from Financing Activities:    
Proceeds from option exercises 59 492
Principal payments on term loan   (5,000)
Net cash provided by financing activities 117,797 15,574
Net increase (decrease) in cash, cash equivalents and restricted cash 81,834 (1,967)
Cash, cash equivalents and restricted cash at beginning of period 120,147 102,920
Cash, cash equivalents and restricted cash at end of period 201,981 100,953
Supplemental cash flow information:    
Cash paid for interest 2,441 444
Supplemental disclosures of non-cash information:    
Issuance costs in accounts payable and accrued expense   638
Capital expenditures in accounts payable and accrued expenses 68 13
Public Offering [Member]    
Cash Flows from Financing Activities:    
Proceeds from issuance of common stock in offering 93,488  
Registered Direct Offering    
Cash Flows from Financing Activities:    
Proceeds from issuance of common stock in offering   15,044
At-the-Market Offering [Member]    
Cash Flows from Financing Activities:    
Proceeds from sale of common stock through at-the-market offerings, net of issuance costs $ 24,250 $ 5,038